Skip to main content
. 2023 May 17;55(4):1104–1112. doi: 10.4143/crt.2023.502

Table 3.

In-field target and out-field target of patients who received proton therapy (n=25)

Patient No. In-field target Out-fieldtarget
1 Left maxillary mass Left upper lobe nodule
2 Left parotid mass Mediastinal lymph node
3 Liver mass Abdominal lymph node
4 Right neck lymph node Left neck mass
5 Liver mass Nasal cavity mass
6 Left upper lobe mass Left lower lobe nodule
7 Right maxillary mass Left neck lymph node
8 Subcarinal lymph node Left. supraclavicular lymph node
9 Right lower lobe mass Right upper lobe mass
10 Left oral cavity mass Right neck lymph node
11 Oral cavity mass Left neck nodule
12 Left posterior neck skin nodules Left chest wall
13 Right retrobulbar mass Right lower lobe mass
14 Left subcutaneous neck nodule Right oropharynx
15 Left neck lymph node Left submandibular area lesion
16 Left submandibular mass Hypopharyngeal mass
17 Mediastinal lymph node Right neck mass
18 Right neck node Left lower lobe mass
19 Larynx Mediastinal lymph node
20 Right peri-parotid mass Left lower lobe mass
21 Left neck lymph node Right neck mass
22 Left upper lobe Sinonasal mass
23 Left anterior chin Left submandibular nodule
24 Right upper lobe mass Left lower lobe nodule
25 Left submandibular mass Mediastinal lymph node